http://www.ibogaine.org/intdrugpol09.html

2009 International Drug Policy Reform Conference

Albuquerque Convention Center -- Albuquerque, New Mexico
November 11 - 14, 2009
IBOGAINE SESSION

Ibogaine: Medical Practice, Science, and African Heritage

Saturday, November 14, 2009, 3:00 PM - 4:30 PM
room to be announced


Moderator
Howard Lotsof -- Dora Weiner Foundation, Staten Island, NY - Mr.
Lotsof is the recipient of this year's Robert Randall Award for
Achievement in the Field of Citizen Action
Presentations

Ibogaine in opioid detoxification: How do we know it works? How does
it work? (The most often asked patient question)

Kenneth Alper, M.D. -- Associate Professor of Psychiatry and Neurology
-- New York University School of Medicine. USA

Safety Issues and Cardiac Side-Effects in the Administration of
Ibogaine HCl, as an Addiction Interrupter Drug. What we know, what we
theorize and what we don't know.

Jeffrey D. Kamlet, MD, FASAM, DABAM -- Fellow, American Society of
Addiction Medicine. USA

Ibogaine User Self-Help Groups: Cross Cultural Development

Dimitri Mobengo Mugianis -- Founding member, NYCAHN/VOCAL, NYC Drug
Users Union. USA Ibogalife

An exploratory study of the short term effects of Ibogaine Treatment

Dr Anwar Jeewa, BDS, HRST, MSocSc -- Director - Minds Alive. South
Africa Minds Alive

The Benefits & Risks of Treating with Ibogaine in a Clinical Setting:
3 Case Studies

Clare S. Wilkins -- Director, Pangea Biomedics.   Mexico   Pangea
Biomedics

Bwiti and iboga, Working properly and safely with iboga or ibogaine
and Ibogaine
antidotes
Patrick Moughenda Mickala, Nganga, Massango and Mitsogho tribe, Gabon
Iboga House
***

http://www.ibogaine.org/intdrugpol09.html